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INTRODUCTION
S omatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs), which also can self-renew and differentiate into cells of three germ layers as embryonic stem cells (ESCs), by the related transcriptional factors Oct4, Klf4, Sox2, and cMyc as first reported by Takahashi and Yamanaka [1] .
Owing to their abilities to replicate unlimitedly and to differentiate into numerous cell types, generation of iPSCs was regarded as one of the most outstanding breakthroughs in the field of stem cell research. During the following years, there have been significant advances in iPSCs generation, such as generated in a broad range of species and from various cell types [2] . These groundbreaking steps have been expected to evolve to novel regenerative cell therapies with the potential to solve many problems surrounding incurable diseases, such as spinal cord injury [3] , neurodegenerative disease [4] , heart failure [5] [6] , diabetes [7] , and retinal disease [8] . In particular, the clinical application of iPSCs is expected to solve the problems of immune rejection and ethics that are key obstacles in the current clinical use of ESCs.
A large number of the iPSC lines were generated using genetic manipulation, which is a highly efficient and reproducible method. However, small sequences of the DNA are integrated with the genes coding for reprogramming factors frequently in this process, which raises a major safety issue and has hindered the potential clinical applications of iPSCs. Furthermore, these permanent insertions, such as cMyc known as an oncogene in human cells, potentially increase the risk of tumor formation [9] [10] . Moreover, the transgenes can potentially disrupt functional genes even if they are silenced or not expressed. To minimize or avoid the side effects resulting from exogenous DNA integration, a number of methods have been developed to produce iPSCs with potentially reduced risks. For example, substitution of the retrovirus vector with adenovirus vector, which integrate into the genome of target cells at extremely low frequencies and will not transfer residual transgenes into the host genomes [11] . Also nonviral reprogramming systems, such as PiggyBac and Sleeping Beauty transposon systems have been adopted [12] . In addition, the Sendai virus, as negative-sense single-stranded RNA does not pose a danger of genome insertion, was also successfully used to generate iPSCs [13] [14] . Besides, the direct delivery of synthetic mRNAs of the four transcriptional factors has been shown to successfully
reprogram somatic cells to a pluripotent state [15] [16] . Smallmolecule drugs have attracted much attention as another way to avoid introducing genetic material. Deng group completed the Chemical iPSCs (CiPSCs) prepared from mouse embryonic fibroblast cells solely using a cocktail of seven smallmolecule compounds [17] . Although these methods significantly reduced genome integration, the reprogramming efficiency is influenced at a great extent. Besides, the instability of some nonintegrative systems (such as mRNA delivery) makes the entire reprogramming procedure laborious. Similarly, direct delivery of recombinant proteins was also reported as a successful means of gene introduction for generating iPSCs [18] [19] . These protein-based methods are also attractive for clinical application owing to the absence of breaks in existing host genes and the reactivation of transgenes, which is an important safety advantage for human therapy.
The critical step in this method is to produce large quantities of pure and bioactive proteins. Pan et al [20] obtained the recombinant TAT-fused proteins of Sox2, Oct4, Lin28, and Nanog from insect cell in 2014. Unfortunately, most of the recombinant proteins remained in the nuclei of the Sf9 insect cells, and were much difficult to purify. As indicated above, insect cell expression vector system is not ideal for the highvolume production of these proteins. The E. coli expression vector system can produce a high yield of target proteins with low cost and simple purification procedures in a short time.
However, the recombinant proteins usually exist in the form of inclusion bodies in commonly-used expression systems such as pET systems, which need laborious denaturation and refolding [18] . The bioactivity of the recombinant proteins may be impaired by the treatments of denaturizing and refolding thus rendered them useless for reprogramming. In present study, we established a new method to improve the solubility of the recombinant proteins and constructed the transactivator transcription (TAT) and the nuclear localization signal (NLS) sequences to the proteins to guarantee the cell-penetrating capacity. 
MATERIALS AND METHODS

Materials
DISCUSSION
In this study, we aimed to prove the feasibility of producing soluble and bioactive reprogramming proteins for iPSCs generation in E. coli, which is the most widely used approach to produce recombinant proteins. Here, the four recombinant proteins were fused to SUMO tag and the E. coli bacteria containing chaperones was employed as host strain, which can extremely decrease the misfolding of these proteins.
Subsequently, the four reprogramming proteins were expressed in bacteria and purified from soluble fractions successfully.
The fused TAT and NLS sequences facilitate the proteins to penetrate into live cells efficiently. Thus the present described method possessed advantages over other non-DNA introducing strategies. First, it can avoid the introduction of exogenous genes absolutely, particularly those that encode intracellular proteins. Second, the recombinant proteins are soluble and bioactive because they have been correctly post-translationally modified and folded. Third, the easily scalable culture is conductive to large-scale production of these recombinant proteins with higher yields. Actually, these purified proteins were quite stable with scarcely precipitation after frozen at -80 ℃ in 10% glycerol for three months. This characteristic Recently, a large number of papers have been published that focused on the safety and efficiency of generation of iPSCs, especially safety [18] [19] . Therefore, for the sake of safe clinical application, nonintegrating or non-DNA overexpression strategies for iPSCs generation should be applied [22] . Recently, several approaches have been developed to generate transgene-free or integration-free cell reprogramming [23] .
Chemical genetics that uses small modulators involved in the regulation of cell states, which is faster, reversible, and more controllable [24] . Another rational approach to achieve nongenetic reprogramming cells is the uses of reprogramming proteins with cell-penetrating peptides (CPPs) [25] . Our recombinant proteins were fused in frame to the TAT peptide sequence derived from the human HIV, and to the NLS sequence, which had a double role of supporting the nuclear localization of the proteins, while minimizing the endosomal/ lysosomal trapping and ultimately the degradation of the cargo [21] . Direct delivery of reprogramming proteins to cells was also reported as a good way to induce the generation of iPSCs. The E. coli expression system can produce a high yield of target proteins in a short time with low cost, and the protein purification procedure is simple. Unfortunately, the four recombinant proteins must be released from the inclusion bodies under denaturing conditions in E. coli expression system [19] . Meanwhile, insect cells also can be selected as the expression host. However, none of these recombinant proteins were expressed as secreted proteins, and all of them were detected only in the cell debris. This characteristic of these proteins made purification difficult and limited their utility [20] .
Although the direct transduction of reprogramming proteins to live cells has been proved to be a successful method to induce iPSCs, the reprogramming efficiency remains to be an issue that deserves consideration. The reprogramming efficiency of purified protein transduction appears to be lower than that of gene introduction, which maybe caused by the cellular uptake mechanisms [21] . The combinative uses of small molecule VPA regimen and recombinant proteins with CPPs showed significantly higher reprogramming efficiency than their separate application [18, 26] . The efficacy of reprogramming is also influenced by the protein concentration and the frequency of the treatment [26] . In several reprogramming systems, improvement was achieved by the addition of certain small molecules [27] [28] . In view of these findings, further optimization of the process to increase the reprogramming rate will be investigated in our further study.
